Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases

Published:2022-02-18 Issue:3 Volume:31 Page:291-303
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Tang Su’an¹²,Yu Qinghong³,Ding Changhai¹⁴^ORCID

Affiliation:

1. Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China

2. Centre of Orthopedics, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China

3. Department of Rheumatology and Clinical Immunology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China

4. Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2022.2040014

Reference104 articles.

1. Human autoimmune diseases: a comprehensive update

2. Autoantibodies as predictors of disease

3. A New Look at Syk in αβ and γδ T Cell Development Using Chimeric Mice with a Low Competitive Hematopoietic Environment

4. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs

5. Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HL-60 cells as a valuable model to study LPS-induced neutrophil extracellular traps release;Heliyon;2024-08

2. A novel natural Syk inhibitor suppresses IgE-mediated mast cell activation and passive cutaneous anaphylaxis;Bioorganic Chemistry;2024-05

3. FGF21 overexpression alleviates VSMC senescence in diabetic mice by modulating the SYK-NLRP3 inflammasome-PPARγ-catalase pathway;Acta Biochimica et Biophysica Sinica;2024-05-01

4. Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers;ACS Medicinal Chemistry Letters;2024-04-18

5. Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors;SAR and QSAR in Environmental Research;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3